153 related articles for article (PubMed ID: 12047591)
1. Methylphenidate hydrochloride for excessive daytime sleepiness in a patient with myotonic dystrophy.
Miyamoto T; Miyamoto M; Suga T; Aizawa C; Takekawa H; Hirata K
Psychiatry Clin Neurosci; 2002 Jun; 56(3):271-2. PubMed ID: 12047591
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
Puymirat J; Bouchard JP; Mathieu J
Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.
Dauvilliers YA; Laberge L
Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566
[TBL] [Abstract][Full Text] [Related]
4. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
Gibbs JW; Ciafaloni E; Radtke RA
Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hypersomnolence in myotonic dystrophy with a CNS stimulant.
van der Meché FG; Boogaard JM; van den Berg B
Muscle Nerve; 1986 May; 9(4):341-4. PubMed ID: 3713739
[TBL] [Abstract][Full Text] [Related]
6. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
7. Sleep disorders in childhood-onset myotonic dystrophy type 1.
Quera Salva MA; Blumen M; Jacquette A; Durand MC; Andre S; De Villiers M; Eymard B; Lofaso F; Heron D
Neuromuscul Disord; 2006 Oct; 16(9-10):564-70. PubMed ID: 16934465
[TBL] [Abstract][Full Text] [Related]
8. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?
Laberge L; Dauvilliers Y; Bégin P; Richer L; Jean S; Mathieu J
Neuromuscul Disord; 2009 Jun; 19(6):397-402. PubMed ID: 19403309
[TBL] [Abstract][Full Text] [Related]
9. Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors.
Seneviratne U; Puvanendran K
Sleep Med; 2004 Jul; 5(4):339-43. PubMed ID: 15222989
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of daytime sleepiness.
Schwartz JR
J Clin Psychiatry; 2004; 65 Suppl 16():46-9. PubMed ID: 15575805
[TBL] [Abstract][Full Text] [Related]
11. Two cases of HLA-DR2-negative hypersomnia manifesting sleep-onset rapid eye movement periods in the multiple sleep latency test.
Yoshida Y; Kuroda K; Mandai M; Satani S; Emura N; Ueda S; Matsumura H; Yoneda H
Psychiatry Clin Neurosci; 1999 Apr; 53(2):295-7. PubMed ID: 10459716
[TBL] [Abstract][Full Text] [Related]
12. Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.
Sansone VA; Proserpio P; Mauro L; Biostat AL; Frezza E; Lanza A; Rogliani P; Pezzuto G; Falcier E; Aggradi CF; Pirola A; Rao F; Roma E; Galluzzi C; Spanetta M; Cattaneo F; Rubino A; Agostoni EC; Amico F; Zanolini A; Izzi F; Greco G; Romigi A; Liguori C; Nobili L; Placidi F; Massa R
J Clin Sleep Med; 2021 Dec; 17(12):2383-2391. PubMed ID: 34170223
[TBL] [Abstract][Full Text] [Related]
13. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
[TBL] [Abstract][Full Text] [Related]
14. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders.
Lombardi C; Parati G; Cortelli P; Provini F; Vetrugno R; Plazzi G; Vignatelli L; Di Rienzo M; Lugaresi E; Mancia G; Montagna P; Castiglioni P
J Sleep Res; 2008 Sep; 17(3):263-70. PubMed ID: 18503513
[TBL] [Abstract][Full Text] [Related]
15. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
16. Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness.
Donadio V; Liguori R; Vetrugno R; Contin M; Elam M; Wallin BG; Karlsson T; Bugiardini E; Baruzzi A; Montagna P
J Sleep Res; 2007 Sep; 16(3):327-32. PubMed ID: 17716282
[TBL] [Abstract][Full Text] [Related]
17. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.
Laberge L; Bégin P; Dauvilliers Y; Beaudry M; Laforte M; Jean S; Mathieu J
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):642-6. PubMed ID: 19211594
[TBL] [Abstract][Full Text] [Related]
18. [Narcolepsy in children].
Martínez-Salcedo E; Lloret-Sempere T; García-Navarro M; Sellés-Gallana MF
Rev Neurol; 2001 Dec 1-15; 33(11):1049-53. PubMed ID: 11785033
[TBL] [Abstract][Full Text] [Related]
19. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
Poryazova R; Benninger D; Waldvogel D; Bassetti CL
Eur Neurol; 2010; 63(3):129-35. PubMed ID: 20090346
[TBL] [Abstract][Full Text] [Related]
20. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Talbot K; Stradling J; Crosby J; Hilton-Jones D
Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
